Anaplastický velkobuněčný lymfom spojený s prsním implantátem – evoluce v průběhu desetiletí: citační analýza 50 nejcitovanějších článků

1. Keech JA. Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997, 100(2): 554–555.

2. Rastogi P., Riordan E., Moon D., et al. Theories of etiopathogenesis of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2019, 143 (3S): 23S–29S.

3. Swerdlow SH., Campo E., Pileri SA., et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016, 127(20): 2375–2390.

4. Di Napoli A. Achieving Reliable Diagnosis in Late Breast Implant Seromas: From Reactive to Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019, 143(3S): 15S–22S.

5. Collett DJ., Rakhorst H., Lennox P., et al. Cur­rent risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg. 2019, 143 (3S): 30S–40S.

6. Kreutz-Rodrigues L., Shapiro D., Mardini S., et al. Landmarks in facial rejuvenation surgery: the top 50 most cited articles. Aesthet Surg J. 2020, 40(1): NP1–NP7.

7. Uysal E. Top 100 cited classic articles in breast cancer research. Eur J Breast Health. 2017, 13(3): 129–137.

8. Joyce KM., Joyce CW., Kelly JC., et al. Levels of evidence in the plastic surgery literature: a citation analysis of the top 50 ”classic” papers. Arch Plast Surg. 2015, 42(4): 411–418.

9. Paladugu R., Schein M., Gardezi S., et al. One hundred citation classics in general surgical journals. World J Surg. 2002, 26(9): 1099–1105.

10. de Jong D., Vasmel WLE., de Boer JP., et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008, 300(17): 2030–2035.

11. Miranda RN., Aladily TN., Prince HM., et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014, 32(2): 114–120.

12. Hu H., Johani K., Almatroudi A., et al. Bacterial biofilm infection detected in breast implant-associated anaplastic large-cell lymphoma. Plast Reconstr Surg. 2016, 137(6): 1659–1669.

13. Kadin ME., Deva A., Xu H., et al. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2016, 36(7): 773–781.

14. Clemens MW., Medeiros LJ., Butler CE., et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016, 34(2): 160–168.

15. Roden AC., Macon WR., Keeney GL., et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008, 21(4): 455–463.

16. Brody GS., Deapen D., Taylor CR., et al. Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg. 2015, 135(3): 695–705.

17. Kim B., Roth C., Chung KC., et al. Anaplastic large cell lymphoma and breast implants: a systematic review. Plast Reconstr Surg. 2011, 127(6): 2141–2150.

18. Hu H., Jacombs A., Vickery K., et al. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015, 135(2): 319–329.

19. Loch-Wilkinson A., Beath KJ., Knight RJW., et al. breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017, 140(4): 645–654.

20. Aladily TN., Medeiros LJ., Amin MB., et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012, 36(7): 1000–1008.

21. Doren EL., Miranda RN., Selber JC., et al. U.S. epidemiology of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2017, 139(5): 1042–1050.

22. Laurent C., Delas A., Gaulard P., et al. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016, 27(2): 306–314.

23. Kadin ME., Morgan J., Xu H., et al. CD30+ T cells in late seroma may not be diagnostic of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017, 37(7): 771–775.

24. de Boer M., van Leeuwen FE., Hauptmann M., et al. Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol. 2018, 4(3): 335–341.

25. Gaudet G., Friedberg JW., Weng A., et al. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma. 2002, 43(1): 115–119.

26. Miranda RN., Lin L., Talwalkar SS., et al. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med. 2009, 133(9): 1383–1390.

27. Carty MJ., Pribaz JJ., Antin JH., et al. A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg. 2011, 128(3):112e–118e.

28. Newman MK., Zemmel NJ., Bandak AZ., et al. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008, 61(7): 822–825.

29. Thompson PA., Lade S., Webster H., et al. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010, 95(11): 1977–1979.

30. Wong AK., Lopategui J., Clancy S., et al. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol. 2008, 32(8): 1265–1268.

31. Lechner MG., Megiel C., Church CH., et al. Survival signals and targets for therapy in breast implant-associated ALK –⁠ anaplastic large cell lymphoma. Clin Cancer Res. 2012, 18(17): 4549–4559.

32. Berry MG., Stanek JJ. The PIP mammary prosthesis: a product recall study. J Plast Reconstr Aesthet Surg. 2012, 65(6): 697–704.

33. Fritzsche FR., Pahl S., Petersen I., et al. Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer –⁠ a case report. Virchows Arch. 2006, 449(5): 561–564.

34. Lechner MG., Lade S., Liebertz DJ., et al. Breast implant-associated, alk-negative, t-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer. 2011, 117(7): 1478–1489.

35. Li S., Lee AK. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol. 2010, 3(1): 117–127.

36. Srinivasa DR., Miranda RN., Kaura A., et al. Global adverse event reports of breast implant-associated alcl: an international review of 40 government authority databases. Plast Reconstr Surg. 2017, 139(5): 1029–1039.

37. Gidengil CA., Predmore Z., Mattke S., et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. Plast Reconstr Surg. 2015, 135(3): 713–720.

38. Taylor CR., Siddiqi IN., Brody GS., et al. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol. 2013, 21(1): 13–20.

39. Popplewell L., Thomas SH., Huang Q., et al. Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymphoma. 2011, 52(8): 1481–1487.

40. Olack B., Gupta R., Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg. 2007, 59(1): 56–57.

41. Alobeid B., Sevilla DW., El-Tamer MB., et al. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma. 2009, 50(5): 831–833.

42. Blombery P., Thompson ER., Jones K., et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016, 101(9): e387–e390.

43. Taylor KO., Webster HR., Prince HM. Anaplastic large cell lymphoma and breast implants: five Australian cases. Plast Reconstr Surg. 2012, 129(4): 610e–617e.

44. Adrada BA., Miranda RN., Rauch GM., et al. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Treat. 2014, 147(1): 1–14.

45. Bishara MRY., Ross C., Sur M.. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009, 4 : 11.

46. George EV., Pharm J., Houston C., et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol. 2013, 6(8): 1631–1642.

47. Adams WP. Jr, Culbertson EJ., Deva AK., et al. Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: experience in 42,000 implants. Plast Reconstr Surg. 2017, 140(3): 427–431.

48. Thompson PA., Prince HM. Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis. Curr Hematol Malig Rep. 2013, 8(3): 196–210.

49. Story SK., Schowalter MK., Geskin LJ. Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disorders. Oncologist. 2013, 18(3): 301–307.

50. Di Napoli A., Jain P., Duranti E., et al. Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol. 2018, 180(5): 741–744.

51. Roden MW., Miranda RN., Butler CE. Breast implant informed consent should include the risk of anaplastic large cell lymphoma. Plast Reconstr Surg. 2016, 137(4): 1117–1122.

52. Kim B., Predmore ZS., Mattke S., et al. Breast implant-associated anaplastic large cell lymphoma: updated results from a structured expert consultation process. Plast Reconstr Surg Glob Open. 2015, 3(1): e296.

53. Smith TJ., Ramsaroop R. Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast. 2012, 21(1): 102–104.

54. Leberfinger AN., Behar BJ., Williams NC., et al. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg. 2017, 152(12): 1161–1168.

55. Hart AM., Lechowicz MJ., Peters KK., et al. Breast implant-associated anaplastic large cell lymphoma: report of 2 cases and review of the literature. Aesthet Surg J. 2014, 34(6): 884–894.

56. Bautista-Quach MA., Nademanee A., Weisenburger DD., et al. Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules. Clin Breast Cancer. 2013, 13(6): 492–495.

57. Johnson L., O’Donoghue JM., McLean N., et al. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol. 2017, 43(8): 1393–1401.

58. Farace F., Bulla A., Marongiu F., et al. Anaplastic large cell lymphoma of the breast arising around mammary implant capsule: an Italian report. Aesthetic Plast Surg. 2013, 37(3): 567–571.

59. Oxford Centre for Evidence-Based Medicine Levels of Evidence. [online]. Avail­able from: https://www.cebm.net/2016/05/ocebm-levels-of-evidence/.

60. Sinha Y., Iqbal FM., Spence JN., et al. A bibliometric analysis of the 100 most-cited articles in rhinoplasty. Plast Reconstr Surg Glob Open. 2016, 4(7): e820.

61. Kim K., Ibrahim AM., Koolen PG., et al. Highest impact articles in microsurgery: a citation analysis. J Reconstr Microsurg. 2015, 31(7): 527–540.

62. Joyce CW., Carroll SM. Microsurgery: the top 50 classic papers in plastic surgery: a citation analysis. Arch Plast Surg. 2014, 41(2): 153–157.

63. Joyce CW., Kelly JC., Carroll SM. The 100 top-cited classic papers in hand surgery. J Plast Surg Hand Surg. 2014, 48(4): 227–233.

64. Mahon NA., Joyce CW., Thomas S., et al. The 50 most cited papers in craniofacial anomalies and craniofacial surgery. Arch Plast Surg. 2015, 42(5): 559–566.

65. Whitney E., Mahato D., Odell T., et al. The 100-most cited articles about craniectomy and hemicraniectomy: a bibliometric analysis. Cureus. 2019, 11(8): e5524.

66. Tahiri Y., Fleming TM., Greathouse T., et al. Analysis of the 50 most cited papers in craniofacial surgery. J Craniomaxillofac Surg. 2015, 43(10): 2152–2157.

67. Chang MT., Schwam ZG., Schutt CA., et al. The 50 most cited articles in facial plastic surgery. Aesthetic Plast Surg. 2017, 41(5): 1202–1207.

68. Muslu Ü. The evolution of breast reduction publications: a bibliometric analysis. Aesthetic Plast Surg. 2018, 42(3): 679–691.

69. Christou P., Antonarakis GS. The 100 most-cited human cleft lip and palate-related articles published in dentistry, oral surgery, and medicine journals. Cleft Palate Craniofac J. 2015, 52(4): 437–446.

70. Mahon NA., Joyce CW. A bibliometric analysis of the 50 most cited papers in cleft lip and palate. J Plast Surg Hand Surg. 2015, 49(1): 52–58.

71. Mbaidjol Z., Rothenberger J., Chetany R. A scientometric analysis of the 50 most cited articles for reconstruction of the lower extremity. Surg Res Pract. 2019, 2019 : 3068028.

72. Wilkins EG., Alderman AK. Breast reconstruction practices in North America: current trends and future priorities. Semin Plast Surg. 2004, 18(2): 149–155.

73. Moghimi M., Fathi M., Marashi A., et al. A scientometric analysis of 20 years of research on breast reconstruction surgery: a guide for research design and journal selection. Arch Plast Surg. 2013, 40(2): 109–115.

74. Joyce CW., Joyce KM., Sugrue CM., et al. Plastic surgery and the breast: a citation analysis of the literature. Plast Reconstr Surg Glob Open. 2(11): e251. 

75. Solomon MJ., Laxamana A., Devore L., et al. Randomized controlled trials in surgery. Surgery. 1994, 115(6): 707–712.

76. van der Linden W. Pitfalls in randomized surgical trials. Surgery. 1980, 87(3): 258–262.

77. Asaad M., Kallarackal AP., Meaike J., et al. Citation skew in plastic surgery journals: does the journal impact factor predict individual article citation rate? Aesthet Surg J. 2020, 40(10): 1136–1142.